Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,032Revenue $M20.9Net Margin (%)-208.5Z-Score18.5
Enterprise Value $M881EPS $-0.3Operating Margin %-211.0F-Score5
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-208.5Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %-2.0Quick Ratio9.5Cash flow > EarningsY
Price/Sales28.75-y EBITDA Growth Rate %-12.9Current Ratio9.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-27.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)9ROE % (ttm)-31.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M238ROI % (ttm)-57.0Gross Margin Increase y-yY

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVAXJean-Marie Eveillard 2014-06-30 Add$3.69 - $5.13
($4.39)
$ 4.3-2%Add 150%500,000
NVAXJean-Marie Eveillard 2014-03-31 Reduce-0.01%$4.13 - $6.65
($5.59)
$ 4.3-23%Reduce -75%200,000
NVAXGeorge Soros 2013-12-31 Sold Out -0.02%$2.76 - $5.16
($3.51)
$ 4.322%Sold Out0
NVAXGeorge Soros 2013-09-30 Buy 0.02%$2.25 - $3.39
($2.82)
$ 4.352%New holding, 573000 sh.573,000
NVAXJean-Marie Eveillard 2013-09-30 Buy 0.01%$2.25 - $3.39
($2.82)
$ 4.352%New holding, 800000 sh.800,000
NVAXJean-Marie Eveillard 2011-03-31 Sold Out $2.15 - $2.96
($2.44)
$ 4.376%Sold Out0
NVAXJean-Marie Eveillard 2010-09-30 Add$2.01 - $2.34
($2.2)
$ 4.396%Add 25%125,000
NVAXJean-Marie Eveillard 2010-06-30 Reduce$2.18 - $2.97
($2.46)
$ 4.375%Reduce -52.65%100,000
NVAXJean-Marie Eveillard 2009-12-31 Buy 0.01%$2.53 - $4.41
($3.46)
$ 4.324%New holding, 250000 sh.250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVAX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVAX Jean-Marie Eveillard 2014-06-30500,0000.210.01+150%
Premium Most recent portfolio changes are included for Premium Members only!


NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Herrmann John A IIISVP, General Counsel 2014-07-31Buy8,950$2.2892.54view
PHILLIPS BARCLAY ASVP, CFO 2014-07-31Buy8,788$2.2892.54view
Wilson Russell PSVP, Business Development 2014-07-31Buy4,989$2.2892.54view
Glenn Gregory MSVP, Research and Development 2014-07-31Buy12,707$2.2892.54view
Hahn Timothy JonSVP, Manufacturing & PD 2014-07-31Buy9,240$2.2892.54view
Erck Stanley CCEO and President 2014-07-31Buy6,788$2.2892.54view
Trizzino JohnSVP, Commercial Operations 2014-06-17Buy5,500$4.51-2.66view
Trizzino JohnSVP, Commercial Operations 2014-06-16Buy16,500$4.51-2.66view
PHILLIPS BARCLAY ASVP, CFO 2014-03-25Buy5,000$4.253.29view
DOUGLAS RICHARDDirector 2014-03-25Buy50,000$4.331.39view

Press Releases about NVAX :

    Quarterly/Annual Reports about NVAX:

    News about NVAX:

    Articles On GuruFocus.com
    comment on NVAX Mar 16 2013 
    comment on NVAX Mar 16 2013 
    Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
    Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
    creiter note on NVAX Jan 03 2010 
    Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
    Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
    Novavax Reports Second Quarter 2009 Financial Results Aug 07 2009 
    Novavax Inc. Reports Operating Results (10-Q) May 11 2009 

    More From Our Partners
    Benzinga's Top Initiations Sep 19 2014 - BENZINGA

    More From Other Websites
    Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy... Sep 16 2014
    Novavax to Host 2nd Annual Analyst and Investor Meeting Sep 11 2014
    ICAAC Presentation: Immunization of Pregnant Baboons With the RSV F Nanoparticle Vaccine Protects... Sep 08 2014
    Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC Sep 06 2014
    CORRECTING and REPLACING -- Novavax to Present RSV Vaccine Preclinical Results at ICAAC Sep 03 2014
    Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC Sep 03 2014
    NOVAVAX INC Financials Aug 15 2014
    Novavax (NVAX) Marked As A Dead Cat Bounce Stock Aug 08 2014
    Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference Aug 07 2014
    NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 07 2014
    Novavax Reports Second-Quarter 2014 Financial Results Aug 06 2014
    Q2 2014 Novavax Earnings Release - After Market Close Aug 06 2014
    Novavax to Host Conference Call to Discuss Second Quarter 2014 Financial Results on August 6, 2014 Jul 30 2014
    Trade-Ideas: Novavax (NVAX) Is Today's "Perilous Reversal" Stock Jul 10 2014
    Novavax Recognized as One of The Washington Post's Top Workplaces Jun 23 2014
    NOVAVAX INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 18 2014
    Insider Trading Alert - UBSI, NVAX And RSG Traded By Insiders Jun 18 2014
    NOVAVAX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 11 2014
    NOVAVAX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... Jun 09 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK